Treating psychiatric comorbidities in patients with epilepsy.

Patients diagnosed with epilepsy frequently encounter psychiatric and behavioral comorbidities, such as anxiety, depression, and ADHD, at rates significantly higher than the general population. This text outlines the pharmacological management of these conditions, emphasizing that effective seizure control often depends on addressing a patient's overall mental health and quality of life. Selective Serotonin Reuptake Inhibitors (SSRIs) are identified as the primary treatment for mood disorders, while atypical antipsychotics like aripiprazole and risperidone are recommended for managing aggression and emotional dysregulation. Additionally, the source evaluates the safety and efficacy of stimulants and nonstimulants for ADHD, noting that medications like methylphenidate are generally well-tolerated. Finally, the author suggests that selecting specific antiseizure medications, such as lamotrigine or valproate, can provide dual benefits by simultaneously stabilizing both seizures and behavioral symptoms.